CLVT
CLARIVATE PLCPrice
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- R Jul 6 Clarivate PLC has signed a definitive agreement to sell its Life Sci…
- R Jul 6 Clarivate announced a definitive agreement to sell its Life Sciences…
- S Aug 3 1 insider sell $4.8M at $1.94
- R Aug 3 Director Andrew Miles Snyder filed a Form 144 to sell 2,489,618 ordi…
- B Aug 6 to Aug 7 2 days of insider buys: $1.7M by 1 insider, avg $1.86
- E Sep 17 M&A: Clarivate Commences Offer to Purchase for Cash Certain of…
Signal stack
Where each data set points today.
- InsidersBEARISH
1 insider bought $1.7M at an average $1.86. 1 insider sold $4.8M.
- InstitutionsMIXED
Q2 2026: 27 added (0 new), 33 trimmed or exited.
- AnalystsMIXED
1 of 12 rate it Buy or better. Every target is above the price.
- EstimatesFALLING
Current-quarter EPS estimate $0.169 → $0.159 over 90 days. 0 up, 2 down in 30 days.
- TrendRANGE
2% above its 50-day average.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| BlackRock, Inc. | ADD | $67.3M |
| FIRST TRUST ADVISORS LP | DOUBLED | $29.2M |
| STATE STREET CORP | ADD | $23.5M |
| GEODE CAPITAL MANAGEMENT, LLC | ADD | $21.8M |
| PRUDENTIAL FINANCIAL INC | TRIM | $17.4M |
| UBS Group AG | TRIM | $12.0M |
| NORTHERN TRUST CORP | ADD | $7.6M |
| MORGAN STANLEY | TRIM | $6.5M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
12 analystsPrice is below the lowest target. Median implies +36%.Targets as of Oct 27, 2026.
| Date | Firm | Rating |
|---|---|---|
| Jul 30, 2026 | Citigroup MAINTAIN | Neutral |
| Jul 30, 2026 | Goldman Sachs MAINTAIN | Neutral |
| Jul 30, 2026 | Stifel MAINTAIN | Buy |
| Jul 30, 2026 | Barclays MAINTAIN | Underweight |
| Jul 7, 2026 | Barclays MAINTAIN | Underweight |
Insider ledger
Form 4| Date | Insider | Type | Value |
|---|---|---|---|
| Oct 6, 2026 | Levy Henry President, LS&H | TAX W/H | $387.5K |
| Sep 30, 2026 | Cornick Kenneth L. Director | AWARD | $28.7K |
| Sep 30, 2026 | Bomba Jane L Okun Director | TAX W/H | $302.27 |
| Sep 30, 2026 | Snyder Andrew Miles Director | AWARD | $51.2K |
| Sep 30, 2026 | Bomba Jane L Okun Director | AWARD | $28.7K |
| Sep 30, 2026 | Snyder Andrew Miles Director | TAX W/H | $1.7K |
| Sep 30, 2026 | Cornick Kenneth L. Director | TAX W/H | $5.8K |
| Aug 15, 2026 | Lisowski Matthew J. Senior VP, CAO | AWARD | 67,357 sh |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | $0.16 | $0.16–$0.16 | +0.0% | $490.1M |
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | $0.72 | $0.71–$0.73 | +0.7% | $2.2B |
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 15, 2026SecBot reports
10 filings · 1 press release · 1 bullish · 1 bearish · 2 mixed · 6 neutral- NEUTRAL 8-K/AOct 13, 2026
Clarivate filed this 8-K/A to provide pro forma financials for the completed sale of its Life…
The sale simplifies Clarivate's structure and reduces leverage, but the remaining business still shows a pro forma net loss. Monitor the Q3 2026 earnings for actual discontinued operations…
- NEUTRAL 8-KOct 6, 2026
Clarivate completed the sale of its Life Sciences & Healthcare segment to Altaris for total…
Monitor the Q3 2026 earnings call on November 3, 2026, for updated full-year guidance reflecting the divestiture and any details on debt paydown plans. The pro forma financials due by October 13…
- NEUTRAL 8-KSep 24, 2026
Clarivate announced the final results of its cash tender offer to purchase up to $75 million of…
The tender offer reduces Clarivate's outstanding debt by $75 million, a modest deleveraging step. Monitor upcoming quarterly filings for any further debt reduction or refinancing activity, as well…
- NEUTRAL PRESS-RELEASESep 22, 2026
Clarivate Plc announced it will report its Q3 2026 results on November 3, 2026.
All CLVT filing & press-release reports (11)
- 8-K/A reportOct 13, 2026
- 8-K reportOct 6, 2026
- 8-K reportSep 24, 2026
- PRESS-RELEASE reportSep 22, 2026
- PRESS-RELEASE reportSep 17, 2026
- CLUSTER reportAug 10, 2026
- 144 reportAug 3, 2026
- 8-K reportJul 6, 2026
- 8-K reportJul 6, 2026
- 8-K reportJun 8, 2026
- DEFA14A reportApr 1, 2026